0001209191-18-010969.txt : 20180216 0001209191-18-010969.hdr.sgml : 20180216 20180216180502 ACCESSION NUMBER: 0001209191-18-010969 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180215 FILED AS OF DATE: 20180216 DATE AS OF CHANGE: 20180216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pope Todd CENTRAL INDEX KEY: 0001584367 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19437 FILM NUMBER: 18622470 MAIL ADDRESS: STREET 1: C/O TRANSENTERIX STREET 2: 635 DAVIS DRIVE, SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27713 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSENTERIX INC. CENTRAL INDEX KEY: 0000876378 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 112962080 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-765-8400 MAIL ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: SafeStitch Medical, Inc. DATE OF NAME CHANGE: 20080211 FORMER COMPANY: FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC DATE OF NAME CHANGE: 19930328 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-02-15 0 0000876378 TRANSENTERIX INC. TRXC 0001584367 Pope Todd C/O TRANSENTERIX, INC. 635 DAVIS DRIVE, SUITE 300 MORRISVILLE NC 27560 1 1 0 0 President and CEO Stock Options 0.00 2018-02-15 4 J 0 403000 0.00 D 2028-02-07 Common Stock 403000 1000000 D Restricted Stock Units 0.00 2018-02-15 4 A 0 268667 0.00 A Common Stock 268667 268667 D A portion of a stock option grant made on February 7, 2018 was rescinded by the Compensation Committee of the Board of Directors, as the original stock option grant inadvertantly exceeded (by 403,000 stock options) the 1,000,000 annual share limitation available for 2018 under the Company's Amended and Restated Incentive Compensation Plan, as amended (the "Incentive Plan"). The terms of the remainder of the stock option grant, now to acquire 1,000,000 shares of common stock, remain in full force and effect. Vests 25% on the first anniversary of the date of grant and 1/48th of the entire award monthly on the vesting date anniversary for 36 months, subject to acceleration as set forth in the Incentive Plan. Each restricted stock unit represents the right to receive one share of the Registrant's common stock. Forfeiture restrictions will lapse on the restricted stock units in three annual installments of one-third of the award (89,555, 89,556 and 89,556) on each of February 4, 2019, 2020 and 2021, respectively, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan. /s/ Joshua Weingard,as Attorney-in-Fact for Todd Pope 2018-02-16